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Realm of Revertant 
Mosaicism Expanding
Marcel F. Jonkman1 and Anna M.G. Pasmooij1
In this issue, Lai-Cheong et al. report a patient with Kindler syndrome who 
showed revertant mosaicism: a patch of normal-looking skin attributable to a 
reverse mutation. The molecular basis of the reverted patch appeared to be the 
deletion of a duplicated cytosine, thus restoring the reading frame of FERMT1 
transcripts. This finding further pushes the frontier of revertant mosaicism, a 
phenomenon of spontaneous gene repair, which can be seen with the naked 
eye in skin.
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Revertant mosaicism is universal
When Charles Darwin formulated his 
evolution theory in his 1859 book, 
On the Origin of Species by Means of 
Natural Selection, or, the Preservation 
of Favoured Races in the Struggle for 
Life, he may not have imagined that 
it also holds true for somatic cells 
within a single organism. If an organ-
ism is affected by a germline muta-
tion, spontaneous repair of the mutant 
gene in somatic cells that express the 
gene product may start a struggle of 
natural selection between revertant 
and mutant cells. When revertant cells 
expand because they have a growth 
advantage, revertant tissue develops, 
also called “natural gene therapy.”
At the “Natural Gene Therapy of the 
Skin” symposium held 7 November 
2011 in Barcelona as a satellite of the 
European Society for Dermatological 
Research meeting, Clifford Weil, plant 
biologist from Purdue University, 
Indiana, explained that in plants 
somatic mutation (variegation) and 
somatic reversion have been observed 
for thousands of years (Figure 1). It was 
in the 1950s that Barbara McClintock 
formulated the molecular theory 
of somatic reversion of “unstable 
mutations”: sections of chromosomes 
proposed to move into and out of 
genes. For her work on transposons she 
was awarded the Nobel Prize in 1983.
Revertant mosaicism was demonstrated 
in blood, muscle, liver, and skin
In humans, revertant mosaicism (RM) 
has been reported in genetic disor-
ders affecting self-regenerating organ 
systems, such as blood, muscle, liver, 
and skin (for reviews, see Jonkman, 
1999; Hirschhorn, 2003; Lai-Cheong 
et al., 2011). The genetic mechanisms 
underlying spontaneous gene repair in 
humans are mostly second-site muta-
tions (single-nucleotide transversions/
transitions and deletions) and homolo-
gous recombinations.
To observe RM in blood, muscle, or 
liver, a microscope and special stain-
ing are required, but in skin RM is vis-
ible to the naked eye. RM in skin was 
first reported by Jonkman et al. (1997) 
in the genetic disorder epidermoly-
sis bullosa (EB), which is character-
ized by lifelong fragile skin that easily 
forms blisters and erosions. Mutations 
in as many as 15 genes can result in 
EB. Four of these genes have shown 
to revert: KRT14 encoding keratin 14 
in EB simplex, LAMB3 encoding the 
β3 chain of laminin-332 (Pasmooij et 
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al., 2007), COL17A1 encoding type 
XVII collagen (Jonkman et al., 1997; 
Pasmooij et al., 2005) in general-
ized non-Herlitz junctional EB, and 
COL7A1 encoding type VII collagen in 
recessive dystrophic EB (Almaani et al., 
2010; Pasmooij et al., 2010; Van den 
Akker et al., 2011).
Initially, RM was thought to be a 
rare phenomenon. Recently, how-
ever, we showed that at least 35% of 
patients with non-Herlitz junctional 
EB, owing to mutations in COL17A1 
or LAMB3, carry revertant patches, 
indicating that RM is more common 
than previously thought (Jonkman 
and Pasmooij, 2009). These clini-
cally healthy skin areas manifested 
as patches of homogeneously pig-
mented skin in patients with COL17A1 
mutations. Another example of the 
relatively high frequency of in vivo 
reversions is the presence of innumer-
able pale, confetti-like revertant spots 
that appear across the body in patients 
with ichthyosis with confetti, the result 
of dominant KRT10 mutations that 
change the reading frame and produce 
an arginine-rich C-terminal peptide 
that induces homologous recombina-
tions (Choate et al., 2010).
Revertant mosaicism in 
Kindler syndrome
Kindler syndrome (KS, OMIM #173650) 
is a form of EB that results from loss-
of-function mutations in the FERMT1 
(KIND1; OMIM #607900) gene encod-
ing kindlin-1. KS is characterized by 
congenital skin blistering and mild 
photosensitivity, evolving to poiki-
loderma and pronounced skin atro-
phy of the hands and feet (Has et al., 
2011). In this issue, Lai-Cheong et al. 
report an eight-year-old child with KS, 
caused by a homozygous mutation, 
FERMT1:c.676dupC; p.Gln226fxX17, 
inherited from his consanguineous 
parents. From the age of three, the 
boy had a patch of normal-appear-
ing skin on the dorsum of one hand. 
Immunofluorescence staining for kind-
lin-1 in affected skin was reduced along 
the dermo-epidermal junction but nor-
mal in the revertant skin. Secondary 
effects of the kindlin-1 restoration were 
normalization of the disorganized label-
ing pattern of laminin-332 and type VII 
collagen and increased activity of the 
β1-integrin subunit.
The molecular basis of the reversion 
appeared to be a deletion of a cytosine, 
FERMT1:c.676dupC; p.Gln226fxX17. 
The wild-type FERMT1 has seven cyto-
sines in repeat in exon 5. In the germ-
line the last C at base pair 676 was 
duplicated, making a stretch of eight 
that resulted in a homozygous frame-
shift, which resulted in nonsense 
mRNA decay. In whole-skin samples 
of revertant skin, the mutation was no 
longer present at the complementary 
DNA level: sequence analysis showed 
a normal run of seven cytosines pres-
ent in exon 5. Surprisingly, sequence 
analysis of genomic DNA extracted 
from revertant KS skin from the pro-
band showed a homozygous stretch 
of eight cytosines in exon 5 of the 
FERMT1 gene, matching the mutant 
gene. This discrepancy between 
mutant DNA and revertant RNA cop-
ies from revertant skin might be caused 
by the whole skin sample that was 
taken or the culture conditions of the 
keratinocytes. Reversion events in 
EB skin are confined to the keratino-
cytes and do not affect the fibroblasts 
in the dermis (Pasmooij et al., 2005, 
2007). At the genomic DNA level the 
mutant fibroblasts and mutant kera-
tinocytes (micromosaicism) in the 
whole-skin sample contaminate rever-
tant keratinocytes, whereas at the RNA 
level only FERMT1 copies from rever-
tant keratinocytes persist, because der-
mal fibroblasts do not transcribe this 
gene and FERMT1 copies from mutant 
keratinocytes are decayed. Even kerati-
nocyte cultures in vitro may not reflect 
the revertant:mutant ratio in the skin 
and skew to the mutant cell popula-
tion. Laser dissection microscopy, 
however, allows revertant cells to be 
Figure 1. Revertant mosaicism in maize. The kernels of normal maize are purple; yellow maize is a 
mutant inbreed. Recurrence of purple spots in kernels are attributable to somatic reversion.
Figure 2. Revertant mosaicism in skin. Keratin 14 reexpression in a revertant patch in recessive 
epidermolysis bullosa simplex. Cellular micromosaicism discloses an epidermal proliferative unit of 
mutant keratinocytes (arrow).
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separated from the rest of the tissue 
sample and examined for molecu-
lar repair on DNA and RNA levels 
(Pasmooij et al., 2005, 2007).
What is the mechanism of gene repair?
Because the reverse mutation was 
not demonstrated in genomic DNA, 
the investigators could only specu-
late about the mechanism by which 
it was achieved. They suggest RNA 
editing, a posttranscriptional process 
that changes the nucleotide sequence 
of an mRNA transcript from the DNA 
sequence. However, deletion of a base 
pair in mRNA has not been reported 
in mammals to date. Another option is 
transcription slippage of the cytosine 
repeat during transcription, but the 
homozygous mRNA population argues 
against this.
We speculate instead that slippage 
during DNA replication may have 
occurred, resulting in deletion of the 
redundant cytosine. If this was missed 
in genomic DNA because of mixed 
revertant/mutant cell isolation, then 
a common mutational mechanism of 
slipped-strand mispairing (Levinson 
and Gutman, 1987) might underlie 
the reversion in the FERMT1 gene. 
This explanation requires further study 
in other patients with the recurrent 
c.676dupC FERMT1 mutation (Has et 
al., 2011).
Growth of the revertant patch
Clonal expansion of a revertant cell to 
form a clinically visible patch of skin 
may take several years. The patch was 
first noted in the current patient at the 
age of three, when it was approxi-
mately ~0.5 cm. When he was six, the 
patch reached its relative full size and 
grew the following two years to 3 cm, 
in parallel with the growth of his hand. 
It is not known how much epidermis 
is replaced by a single stem cell pro-
genitor. From our experience, and 
from reports of patients with ichthyo-
sis with confetti (Choate et al., 2010), 
it appears that revertant patches may 
not grow larger than about 5–10 cm. 
Taking into account that an epider-
mal proliferative unit consists of about 
10–11 basal keratinocytes at a density 
of 1,400 units/mm2 of skin (Allen and 
Potten, 1974) (Figure 2), one epidermal 
progenitor cell may provide stem cells 
for up to 14 million epidermal prolif-
erative units. The patch of the current 
patient seemed to have reached its rel-
ative size, and will probably only grow 
in parallel with the size of his hand 
until adulthood.
Perspectives
RM has now been recognized in many 
patients. In the future, revertant kerati-
nocytes might be used for revertant cell 
therapy. One course of action might 
be to culture the naturally corrected 
cells to form epidermal sheets that can 
be transplanted onto affected EB skin 
(Gostynski et al., 2009). Another possi-
bility is to use revertant cells in induced 
pluripotent stem cell technology to 
secure their regenerative potential. 
Two roads are currently open: (i) dif-
ferentiate revertant induced pluripotent 
stem cells into keratinocytes and grow 
sheets for grafting and (ii) differentiate 
into bone marrow stem cells, which 
may home into bone marrow and into 
blistered areas of the skin following 
autologous intravenous transplantation. 
Patients with KS may be considered for 
these avenues of treatment when and if 
they become available.
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Clinical Implications
•  Kindler syndrome is among the expanding list of genodermatoses that 
display revertant mosaicism.
•  Revertant skin patches in Kindler syndrome can grow during childhood.
•  Revertant events may arise from slipped mispairing in direct nucleotide 
repeats in Kindler syndrome.
•  Revertant mosaicism may lead to new avenues of therapy.
